Today only

You are receiving this message because you opted in to receive information about our upcoming campaigns from InvestorPlace. If you don’t want to receive messages about this campaign in the future you can unsubscribe here but you will no longer receive reminders and supporting content for this campaign.   Dear Reader, I hope you made it to Matt McCall’s online event, the Blockbuster FDA Approval Summit 2019. If you weren’t able to view Matt’s presentation yet, you can watch a recap right now by clicking here. Insiders are saying this Phase 3 treatment is “the biggest improvement in cancer surgery in 50 years” and “an enormous scientific breakthrough.” One tiny, $7 million firm has filed a patent on it and could soar as we move closer to final FDA review. Although this small company is still private, Matt and his team of analysts have figured out a little-known way to purchase shares in its “silent partner” on the public markets. But today is your last chance to receive Matt’s entire analysis – plus more than $14,000 worth of bonuses he’s giving away to all new members. This includes an entire free bonus year to Matt’s elite high-growth technology research advisory. After midnight tonight, this offer will be gone for good. Click here to get in on this extraordinary opportunity while there’s still time. Sincerely, Brian Hunt, CEO, InvestorPlace   MANAGE YOUR INVESTORPLACE ACCOUNT: We hope this timely investing advice is valuable to you. As you know the markets move fast and conditions change frequently. So please check the current issue for the most recent advice. To make sure you received the most recent updates, please tell us if your email has changed by visiting here: https://investorplace.com/ipi/e/ Click here to unsubscribe. InvestorPlace Media, LLC. 9201 Corporate Blvd, Suite 200 Rockville, MD 20850 If you have any questions call 1-800-219-8592. Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. ————————————————————————————————- Please note that we cannot be liable for any missed bulletins caused by overzealous spam filters. To ensure that you continue to receive this valuable part of your service please take a moment to add (BrianHunt@exct.Investorplace.com) to your address book. Click here for instructions: http://www.investorplace.com/whitelist.html?eml=BrianHunt@exct.Investorplace.com